First Time Loading...

WuXi Biologics (Cayman) Inc
HKEX:2269

Watchlist Manager
WuXi Biologics (Cayman) Inc Logo
WuXi Biologics (Cayman) Inc
HKEX:2269
Watchlist
Price: 13.96 HKD -4.12% Market Closed
Updated: May 4, 2024
Section:
 

Relative Value

The Relative Value of one WuXi Biologics (Cayman) Inc stock under the Base Case scenario is 55.02 HKD. Compared to the current market price of 13.96 HKD, WuXi Biologics (Cayman) Inc is Undervalued by 75%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
55.02 HKD
Undervaluation 75%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.2
P/S
P/S
Price to Sales
3.2
vs History
96
vs Industry
53
Median 3Y
14.9
Median 5Y
28.9
Industry
3.9
Forward
3
More Details
16.2
P/E
P/E
Price to Earnings
16.2
vs History
96
vs Industry
34
Median 3Y
50.6
Median 5Y
108.7
Industry
31.1
Forward
12.9
More Details
8.1
P/OCF
P/OCF
Price to OCF
8.1
vs History
96
vs Industry
46
Median 3Y
44.8
Median 5Y
94.5
Industry
23.3
More Details
101.9
P/FCFE
P/FCFE
Price to FCFE
101.9
vs History
15
vs Industry
8
Median 3Y
-84.5
Median 5Y
-106.8
Industry
27.4
More Details
1.4
P/B
P/B
Price to Book Value
1.4
vs History
96
vs Industry
67
Median 3Y
6.4
Median 5Y
9
Industry
2.5
More Details
2.8
EV/S
EV/S
Enterprise Value to Sales
2.8
vs History
95
vs Industry
58
Median 3Y
14.5
Median 5Y
27.7
Industry
3.8
Forward
2.6
More Details
7
EV/GP
EV/GP
Enterprise Value to Gross Profit
7
vs History
95
vs Industry
52
Median 3Y
32.4
Median 5Y
66.1
Industry
7.9
More Details
10.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
10.8
vs History
95
vs Industry
40
Median 3Y
44.4
Median 5Y
85.4
Industry
17.2
Forward
7.2
More Details
10.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
10.8
vs History
95
vs Industry
40
Median 3Y
47.8
Median 5Y
96.6
Industry
22.7
Forward
9.7
More Details
7
EV/OCF
EV/OCF
Enterprise Value to OCF
7
vs History
95
vs Industry
45
Median 3Y
43.4
Median 5Y
91.4
Industry
21.4
More Details
43.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
43.5
vs History
14
vs Industry
16
Median 3Y
-82.7
Median 5Y
-82.7
Industry
27.9
More Details
1.1
EV/IC
EV/IC
Enterprise Value to IC
1.1
vs History
95
vs Industry
68
Median 3Y
5.4
Median 5Y
10.4
Industry
2.4
More Details

Multiples Across Competitors

Competitors Multiples
WuXi Biologics (Cayman) Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
WuXi Biologics (Cayman) Inc
HKEX:2269
59.4B HKD 3.2 16.2 10.8 10.8
US
Thermo Fisher Scientific Inc
NYSE:TMO
221.3B USD 5.2 36.9 22.8 33.4
US
Danaher Corp
NYSE:DHR
184B USD 4.2 22.8 16.6 20.4
CH
Lonza Group AG
SIX:LONN
37.5B CHF 5.6 57.3 19.7 28.9
US
IQVIA Holdings Inc
NYSE:IQV
40.5B USD 2.7 29.9 16.3 25.2
US
Agilent Technologies Inc
NYSE:A
40.9B USD 6.1 33.1 26.4 31.8
KR
Samsung Biologics Co Ltd
KRX:207940
54.9T KRW 14.9 64 33.7 48.6
US
Mettler-Toledo International Inc
NYSE:MTD
26.9B USD 7.1 34.2 23.9 26.5
US
West Pharmaceutical Services Inc
NYSE:WST
26.6B USD 9.1 46.9 32.5 39.5
IE
ICON PLC
NASDAQ:ICLR
25.6B USD 3.1 37.4 16.9 26
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.2B EUR 7.1 75.4 32.4 53.2

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.